Binding of β-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas apoE only modulates binding affinity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 633-637

  De Beer, Femke ^a   Hendriks, Wendy L ^a   Van Vark, Leonie C ^a   Kamerling, Sylvia W A ^a   Van Dijk, Ko Willems ^b   Hofker, Marten H ^b   Smelt, Augustinus H M ^a   Havekes, Louis M ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c TNO   (Netherlands)

Author keywords

apoE; Heparan sulfate proteoglycans; Lipoprotein lipase; VLDL

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; LIPOPROTEIN LIPASE; PROTEOHEPARAN SULFATE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HYPERLIPOPROTEINEMIA TYPE 3; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0033012556     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.633     Document Type: Article

References (42)

1. Singer II, Solomon S, Kawha DW, Hassell JR. Extracellular matrix fibers containing fibronectin and basement membrane heparan sulfate proteoglycan coalign with focal contacts and microfilament bundles in stationary fibroblasts. Exp Cell Res. 1987;173:558-571.
2. Weisgraber KH, Rall SC Jr, Mahley RW, Milne RW, Marcel YL, Sparrow JT. Human apolipoprotein E: determination of the heparin binding sites of apolipoprotein E3. J Biol Chem. 1986;261:2068-2076.
3. Mahley RW, Hussain MM. Chylomicron and chylomicron remnant catabolism. Curr Opin Lipidol. 1991;2:170-176.
4. Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem. 1993;268:10160-10167.
5. Ji ZS, Fazio S, Lee YL, Mahley RW. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem. 1994;269:2764-2772.
6. Ji ZS, Fazio S, Mahley RW. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J Biol Chem. 1994;269:13421-13428.
7. Mann WA, Meyer N, Weber W, Meyer S, Greten H, Beisiegel U. Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia. J Lipid Res. 1995;36:517-525.
8. Oswald B, Shelburne F, Landis B, Linker A, Quarfordt S. The relevance of glycosaminoglycan sulfates to apoE induced lipid uptake by hepatocyte monolayers. Biochem Biophys Res Commun. 1986;141:158-164.
9. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
10. Mahley RW, Ji ZS, Brecht WJ, Miranda RD, He D. Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. Ann N Y Acad Sci. 1994;737:39-52.
11. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996;37:693-707.
12. Bensadoun A. Lipoprotein lipase. Annu Rev Nutr. 1991;11:217-237.
13. Olivecrona T, Bengtsson G, Marklund SE, Lindahl U, Hook M. Heparin-lipoprotein lipase interactions. Fed Proc. 1977;36:60-65.
14. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol. 1995;6:291-305.
15. Mulder M, Lombardi P, Jansen H, van Berkel TJ, Frants RR, Havekes LM. Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins. Biochem Biophys Res Commun. 1992;185: 582-587.
16. Mulder M, Lombardi P, Jansen H, van Berkel TJC, Frants RR, Havekes LM. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulphate proteoglycans via lipoprotein lipase. J Biol Chem. 1993;268:9369-9375.
17. Hendriks WL, van der Boom H, van Vark LC, Havekes LM. Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages. Biochem J. 1996;314:563-568.
18. de Man FHAF, de Beer F, van der Laarse A, Smelt AHM, Havekes LM. Lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase. J Lipid Res. 1997;38:2465-2472.
19. Jong MC, Dahlmans VEH, van Gorp PJJ, Breuer ML, Mol MJTM, van der Zee A, Frants RR, Hofker MH, Havekes LM. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1. Arterioscler Thromb Vasc Biol. 1996;16:934-940.
20. van Vlijmen BJM, van Dijk KW, van 't Hof HB, van Gorp PJJ, van der Zee A, van der Boom H, Breuer ML, Hofker MH, Havekes LM. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158→Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice. J Biol Chem. 1996;271: 30595-30602.
21. van Ree JH, van den Broek WJ, Dahlmans VE, Groot PH, Vidgeon-Hart M, Frants RR, Wieringa B, Havekes LM, Hofker MH. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 1994;111:25-37.
22. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
23. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
24. Lowry OH, Rosebrough RJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
25. Jong MC, Dahlmans VEH, Hofker MH, Havekes LM. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner. Biochem J. 1997;328:745-750.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
27. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972;260:212-221.
28. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci. 1949;51:660-672.
29. Edwards IJ, Xu H, Obunike JC, Goldberg IJ, Wagner WD. Differentiated macrophages synthesize a heparan sulfate proteoglycan and an over-sulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol. 1995;15:400-409.
30. Seo T, St. Clair RW. Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages. J Lipid Res. 1997;38:765-779.
31. Werb Z, Chin JR. Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes. J Cell Biol. 1983;97:1113-1118.
32. Koo C, Innerarity TL, Mahley RW. Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J Biol Chem. 1985;260: 11934-11943.
33. Lookene A, Savonen R, Olivecrona G. Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase: studies by surface plasmon resonance technique. Biochemistry. 1997;36:5267-5275.
34. Goldberg IJ, Kandel JJ, Blum CB, Ginsberg HN. Association of plasma lipoproteins with post-heparin lipase activity. J Clin Invest. 1986;78: 1523-1528.
35. Vilella E, Joven J. Lipoprotein lipase binding to plasma. Med Sci Res. 1991;19:111-112.
36. Vilella E, Joven J, Fernández M, Vilaró S, Brunzell JD, Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Res. 1993;34:1555-1564.
37. Zambon A, Schmidt I, Beisiegel U, Brunzell JD. Dimeric lipoprotein lipase is bound to triglyceride rich plasma lipoproteins. J Lipid Res. 1996;37:2394-2404.
38. Rumsey SC, Obunike JC, Arad Y, Deckelbaum RJ, Goldberg IJ. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest. 1992;90: 1504-1512.
39. O'Brien KD, Gordon D, Deeb S, Ferguson M, Chait A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest. 1992;89:1544-1550.
40. Vijayagopal P. Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells. Biochem J. 1993;294: 603-611.
41. Owens RT, Wagner WD. Metabolism and turnover of cell surface-associated heparan sulfate proteoglycan and chondroitin sulfate proteoglycan in normal and cholesterol-enriched macrophages. Arterioscler Thromb. 1991;11:1752-1758.
42. Mazzone T, Gump H, Diller P, Getz GS. Macrophage free cholesterol content regulates apoE production. J Biol Chem. 1987;262:11657-11662.